169 related articles for article (PubMed ID: 33296755)
21. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors.
Desfeux P; Camatte S; Chatellier G; Blanc B; Querleu D; Lécuru F
Gynecol Oncol; 2005 Sep; 98(3):390-5. PubMed ID: 16043215
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; Poncelet C; Daraï E
Ann Oncol; 2005 Mar; 16(3):403-10. PubMed ID: 15653700
[TBL] [Abstract][Full Text] [Related]
23. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
25. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
26. Management of borderline ovarian tumours.
Gershenson DM
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
[TBL] [Abstract][Full Text] [Related]
27. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours.
Song T; Hun Choi C; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Hum Reprod; 2011 Aug; 26(8):2008-14. PubMed ID: 21511712
[TBL] [Abstract][Full Text] [Related]
28. Controversies in borderline ovarian tumors.
Seong SJ; Kim DH; Kim MK; Song T
J Gynecol Oncol; 2015 Oct; 26(4):343-9. PubMed ID: 26404125
[TBL] [Abstract][Full Text] [Related]
29. Short-term Outcomes and Pregnancy Rate After Laparoscopic Fertility-Sparing Surgery for Borderline Ovarian Tumors: A Single-Institute Experience.
Zhao J; Liu C; Liu J; Qu P
Int J Gynecol Cancer; 2018 Feb; 28(2):274-278. PubMed ID: 29324543
[TBL] [Abstract][Full Text] [Related]
30. Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours.
Gaurilcikas A; Gedgaudaite M; Cizauskas A; Atstupenaite V; Paskauskas S; Gaurilcikiene D; Birzietis T; Vaitkiene D; Nadisauskiene RJ
Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322438
[No Abstract] [Full Text] [Related]
31. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery.
Delle Marchette M; Ceppi L; Andreano A; Bonazzi CM; Buda A; Grassi T; Giuliani D; Sina F; Lamanna M; Bianchi T; Lissoni AA; Landoni F; Valsecchi MG; Fruscio R
Eur J Cancer; 2019 Apr; 111():61-68. PubMed ID: 30826658
[TBL] [Abstract][Full Text] [Related]
32. Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.
Gokcu M; Gungorduk K; Aşıcıoğlu O; Çetinkaya N; Güngör T; Pakay G; Cüylan ZF; Toptaş T; Özyurt R; Ağaçayak E; Ozdemir A; Erol O; Turan A; Gülseren V; İcen MS; Şenol T; Güraslan H; Yücesoy B; Sahbaz A; Gungorduk O; Besimoğlu B; Pakay K; Temizkan O; Sancı M; Şimşek T; Meydanlı MM; Harma M; Yaşar L; Boran B; Uysal AD; Karateke A
J Ovarian Res; 2016 Oct; 9(1):66. PubMed ID: 27756415
[TBL] [Abstract][Full Text] [Related]
33. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
34. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
35. Borderline ovarian tumor in pregnancy: can surgery wait? A case series.
Vidal Urbinati AM; Iacobone AD; Di Pace RC; Pino I; Pittelli MR; Guerrieri ME; Preti EP; Franchi D
Arch Gynecol Obstet; 2021 Dec; 304(6):1561-1568. PubMed ID: 33950305
[TBL] [Abstract][Full Text] [Related]
36. Borderline ovarian tumors and fertility.
Nam JH
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):227-34. PubMed ID: 20386444
[TBL] [Abstract][Full Text] [Related]
37. Recurrence characteristics and clinicopathological results of borderline ovarian tumors.
Niu L; Tian H; Xu Y; Cao J; Zhang X; Zhang J; Hou J; Lv W; Wang J; Xin L; Dong X; Xu T; Nan Y; Wei H; Chai X; Li N; Ni Y; Shang Y; Zhang L; Zhao Y
BMC Womens Health; 2021 Mar; 21(1):134. PubMed ID: 33789656
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
[TBL] [Abstract][Full Text] [Related]
39. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].
Bourdel N; Huchon C; Cendos AW; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chéreau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):223-235. PubMed ID: 32004780
[TBL] [Abstract][Full Text] [Related]
40. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary.
Camatte S; Morice P; Pautier P; Atallah D; Duvillard P; Castaigne D
BJOG; 2002 Apr; 109(4):376-80. PubMed ID: 12013157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
